CAR-T Long Term Follow Up (LTFU) Study, CCTL019A2205B (PAVO)
Long TermFollow-Up of Patients Exposed to Lentiviral-Based CD19 directed CART Cell Therapy (PAVO)
Phase II/III, , Multizentrisch, International
Inclusion Criteria: All patients who have received a CAR-T therapy and completed or discontinued early from a Novartis sponsored treatment protocol that utilized CAR-T cells or from any CAR-T trial sponsored by the University of Pennsylvania with which Novartis has a contractual agreement to co-develop the CAR technology. Patients who have provided informed consent for the long term follow up study prior to their study participation . Exclusion Criteria: There are no specific exclusion criteria for this study.
Ihre Ansprechpartnerin im CCC MF